chartexchange

VRTX
Vertex Pharmaceuticals Inc
stockNASDAQ

At CloseOct 13, 2026 3:59:59 PM EDT
485.38USD-4.264%(-21.62)1,187,512
Pre-marketOct 14, 2026 8:14:30 AM EDT
489.00USD+0.779%(+3.78)
After-hoursOct 13, 2026 4:18:30 PM EDT
485.05USD-0.068%(-0.33)
Loading…
Loading…
122.99B
Healthcare
Biotechnology
HQ
Boston, MA, USA
Previous Close
$507.00
Beta
0.50
52-Week High
$560.25 2026-09-03
52-Week Low
$403.16 2025-11-04
SMA 50
$521.35
SMA 200
$475.25
Avg. Vol 10D
1.09M
Avg. Vol 30D
1.04M
Avg. Vol 90D
1.35M
Relative Vol
1.15
253.46M
253.23M
0.2500%
2,000,000
Nov 2, 2026 (19d)
Aug 24, 2000 · 2-for-1
VRTX Profile

Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.

VRTX Performance
PeriodPriceDateChangeBeta
1W505.642026-10-07-4.04%2.232
1M519.512026-09-14-6.60%0.377
3M476.312026-07-14+1.87%0.329
6M444.282026-04-14+9.22%0.250
1Y412.222025-10-14+17.71%0.502
2Y484.822024-10-14+0.09%—
5Y181.902021-10-14+166.76%0.558
VRTX Stock Summary

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) stock price today is $485.23, and today's volume is 1,187,512. VRTX is down 4.294% today. The 30 day average volume is 1.04M. VRTX market cap is $122.99B with 253.46M shares outstanding.